Contact us for information about our services related to polycystic kidney disease (PKD), including mutation screening of cell lines derived from patients with autosomal dominant polycystic kidney disease (ADPKD), mutation screening of large populations with typical ADPKD, genetic screening of families with atypical PKD, the Cystic Kidney and Liver Disease Biobank, collection, fractionation and storage of urine samples, and DNA submission requirements.

Peter C. Harris, Ph.D.

  • Director, Molecular Genetics and Biomarker Core
  • Mayo Clinic Pirnie Translational Polycystic Kidney Disease Center
    Mayo Clinic
    Stabile Building, Seventh Floor
    200 First St. SW
    Rochester, MN 55905
  • Phone: 507-284-2908
  • Email: